Heterogeneity in Estimates of the Impact of Influenza on Population Mortality: A Systematic Review

American Journal of Epidemiology

Volumn 187, Issue 2, 2018, Pages 378-388

  Li, Li ^a,b,c   Wong, Jessica Y ^a   Wu, Peng ^a   Bond, Helen S ^a   Lau, Eric H Y ^a   Sullivan, Sheena G ^b,c   Cowling, Benjamin J ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

epidemiologic methods; influenza; mortality; systematic reviews

Indexed keywords

CAUSE OF DEATH; EPIDEMIOLOGY; HETEROGENEITY; INFLUENZA; MORBIDITY; PUBLIC HEALTH; REGRESSION ANALYSIS; STATISTICAL ANALYSIS;

CAUSE OF DEATH; DISEASE ASSOCIATION; GROUPS BY AGE; HUMAN; INFLUENZA; INFLUENZA VIRUS; METHODOLOGY; MORTALITY; REVIEW; STANDARDIZATION; SYSTEMATIC REVIEW; GLOBAL HEALTH; INFLUENZA A VIRUS; PROCEDURES; REGRESSION ANALYSIS; STATISTICS; STATISTICS AND NUMERICAL DATA;

ORTHOMYXOVIRIDAE;

GLOBAL HEALTH; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; REGRESSION ANALYSIS; STATISTICS AS TOPIC;

EID: 85040600006     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwx270     Document Type: Review

References (121)

1. WorldHealth Organization. Influenza (seasonal). http://www. who. int/mediacentre/factsheets/fs211/en/. AccessedApril 28, 2016.
2. Metersky ML, Masterton RG, Lode H, et al. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. Int J Infect Dis. 2012; 16(5):e321-e331.
3. Lee KH, Gordon A, Foxman B. The role of respiratory viruses in the etiology of bacterial pneumonia: An ecological perspective. Evol Med Public Health. 2016;2016(1):95-109.
4. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: A systematic review. Lancet Infect Dis. 2009;9(10):601-610.
5. Thompson WW, Comanor L, Shay DK. Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis. 2006; 194(suppl 2):S82-S91.
6. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289(2):179-186.
7. Jhung MA, Swerdlow D, Olsen SJ, et al. Epidemiology of 2009 pandemic influenza A (H1N1) in the United States. Clin Infect Dis. 2011;52(suppl 1):S13-S26.
8. Dawood FS, Iuliano AD, Reed C, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: A modelling study. Lancet Infect Dis. 2012;12(9):687-695.
9. Reichert TA, Sugaya N, Fedson DS, et al. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med. 2001;344(12):889-896.
10. Baguelin M, Flasche S, Camacho A, et al. Assessing optimal target populations for influenza vaccination programmes: An evidence synthesis and modelling study. PLoS Med. 2013; 10(10):e1001527.
11. Moher D, Liberati A, Tetzlaff J, et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA statement. J Clin Epidemiol. 2009;62(10):1006-1012.
12. Simonsen L, Viboud C. The art of modeling the mortality impact of winter-seasonal pathogens. J Infect Dis. 2012; 206(5):625-627.
13. Charu V, Simonsen L, Lustig R, et al. Mortality burden of the 2009-10 influenza pandemic in the United States: improving the timeliness of influenza severity estimates using inpatient mortality records. Influenza Other Respir Viruses. 2013;7(5): 863-871.
14. Mølbak K, Widgren K, Jensen KS, et al. Burden of illness of the 2009 pandemic of influenza A (H1N1) in Denmark. Vaccine. 2011;29(suppl 2):B63-B69.
15. Cooper BS, Kotirum S, Kulpeng W, et al. Mortality attributable to seasonal influenza A and B infections in Thailand, 2005-2009: A longitudinal study. Am J Epidemiol. 2015;181(11):898-907.
16. Wu P, Goldstein E, Ho LM, et al. Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009. J Infect Dis. 2012;206(12):1862-1871.
17. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
18. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2008.
19. Cooper H, Hedges LV, Valentine JC. The Handbook of Research Synthesis and Meta-Analysis. 2nd ed. New York, NY: Russell Sage Foundation; 2009.
20. Collins SD, Lehmann J. Excess deaths from influenza and pneumonia and from important chronic diseases during epidemic periods, 1918-51. Public Health Monogr. 1953;10: 1-21.
21. Simonsen L, Spreeuwenberg P, Lustig R, et al. Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: A modeling study. PLoS Med. 2013; 10(11):e1001558.
22. Viboud C, Simonsen L, Fuentes R, et al. Global mortality impact of the 1957-1959 influenza pandemic. J Infect Dis. 2016;213(5):738-745.
23. Presanis AM, Pebody RG, Paterson BJ, et al. Changes in severity of 2009 pandemic A/H1N1 influenza in England: A Bayesian evidence synthesis. BMJ. 2011;343:d5408.
24. Reed C, Chaves SS, Daily Kirley P, et al. Estimating influenza disease burden from population-based surveillance data in the United States. PLoS One. 2015;10(3):e0118369.
25. Shrestha SS, Swerdlow DL, Borse RH, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis. 2011; 52(suppl 1):S75-S82.
26. Aungkulanon S, Cheng PY, Kusreesakul K, et al. Influenzaassociated mortality in Thailand, 2006-2011. Influenza Other Respir Viruses. 2015;9(6):298-304.
27. Wong JY, Wu P, Nishiura H, et al. Infection fatality risk of the pandemic A(H1N1)2009 virus in Hong Kong. Am J Epidemiol. 2013;177(8):834-840.
28. Wu P, Goldstein E, Ho LM, et al. Excessmortality impact of two epidemics of pandemic influenzaA(H1N1pdm09) virus in HongKong. Influenza Other Respir Viruses. 2014;8(1):1-7.
29. Park M, Wu P, Goldstein E, et al. Influenza-associated excess mortality in South Korea. Am J Prev Med. 2016;50(4): e111-e119.
30. Chow A, Ma S, Ling AE, et al. Influenza-associated deaths in tropical Singapore. Emerg Infect Dis. 2006;12(1):114-121.
31. Wong CM, Chan KP, Hedley AJ, et al. Influenza-associated mortality in Hong Kong. Clin Infect Dis. 2004;39(11): 1611-1617.
32. Wong CM, Peiris JS, Yang L, et al. Effect of influenza on cardiorespiratory and all-causemortality in Hong Kong, Singapore andGuangzhou. Hong KongMed J. 2012;18(suppl 2):8-11.
33. Yang L, Chan KP, Cowling BJ, et al. Excess mortality associated with the 2009 pandemic of influenza A(H1N1) in Hong Kong. Epidemiol Infect. 2012;140(9):1542-1550.
34. Yang L, Ma S, Chen PY, et al. Influenza associated mortality in the subtropics and tropics: results from three Asian cities. Vaccine. 2011;29(48):8909-8914.
35. Cheng PY, Palekar R, Azziz-Baumgartner E, et al. Burden of influenza-associated deaths in the Americas, 2002-2008. Influenza Other Respir Viruses. 2015;9(suppl 1):13-21.
36. Green HK, Andrews N, Fleming D, et al. Mortality attributable to influenza in England and Wales prior to, during and after the 2009 pandemic. PLoS One. 2013;8(12):e79360.
37. Kessaram T, Stanley J, Baker MG. Estimating influenzaassociated mortality in New Zealand from 1990 to 2008. Influenza Other Respir Viruses. 2015;9(1):14-19.
38. Lopez-Cuadrado T, de Mateo S, Jimenez-Jorge S, et al. Influenza-related mortality in Spain, 1999-2005. Gac Sanit. 2012;26(4):325-329.
39. Matias G, Taylor R, Haguinet F, et al. Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status. Influenza Other Respir Viruses. 2014;8(5): 507-515.
40. Newall AT, Viboud C, Wood JG. Influenza-attributable mortality in Australians aged more than 50 years: A comparison of different modelling approaches. Epidemiol Infect. 2010;138(6):836-842.
41. Newall AT, Wood JG, Macintyre CR. Influenza-related hospitalisation and death in Australians aged 50 years and older. Vaccine. 2008;26(17):2135-2141.
42. Schanzer DL, Sevenhuysen C, Winchester B, et al. Estimating influenza deaths in Canada, 1992-2009. PLoS One. 2013;8(11):e80481.
43. Tempia S, Walaza S, Viboud C, et al. Mortality associated with seasonal and pandemic influenza and respiratory syncytial virus among children >5 years of age in a high HIV prevalence setting-South Africa, 1998-2009. Clin Infect Dis. 2014;58(9):1241-1249.
44. Tempia S, Walaza S, Viboud C, et al. Deaths associated with respiratory syncytial and influenza viruses among persons 5 years of age in HIV-prevalent area, South Africa, 1998-2009. Emerg Infect Dis. 2015;21(4):600-608.
45. Wijngaard CC, Asten L, Koopmans MP, et al. Comparing pandemic to seasonal influenza mortality: moderate impact overall but high mortality in young children. PLoS One. 2012; 7(2):e31197.
46. Lee VJ, Yap J, Ong JB, et al. Influenza excess mortality from 1950-2000 in tropical Singapore. PLoS One. 2009;4(12): e8096.
47. Linhart Y, Shohat T, Bromberg M, et al. Excess mortality from seasonal influenza is negligible below the age of 50 in Israel: implications for vaccine policy. Infection. 2011;39(5): 399-404.
48. Simonsen L, Clarke MJ, Schonberger LB, et al. Pandemic versus epidemic influenza mortality: A pattern of changing age distribution. J Infect Dis. 1998;178(1):53-60.
49. Ohmi K, Marui E. Estimation of the excess death associated with influenza pandemics and epidemics in Japan after World War II: relation with pandemics and the vaccination system [in Japanese]. Nihon Koshu Eisei Zasshi. 2011;58(10): 867-878.
50. Tachibana T, Kawaminami K, Minowa M. Excess mortality from influenza epidemics in Japan, 1980-1994 [in Japanese]. Nihon Koshu Eisei Zasshi. 1999;46(4):263-274.
51. Takahashi M, Nagai M. Estimation of excess mortality associated with influenza epidemics specific for sex, age and cause of death in Japan during 1987-2005 [in Japanese]. Nihon Eiseigaku Zasshi. 2008;63(1):5-19.
52. Takahashi M, Tango T. Comparative study of new method and the Kawai and Fukutomi methods for estimating excess mortality associated with influenza-epidemics, based upon national vital statistics from 1975 to 1997 [in Japanese]. Nippon Koshu Eisei Zasshi. 2001;48(10):816-826.
53. Takahashi M, Tango T. Estimation of excess mortality associated with influenza-epidemics by age and cause specific death in Japan, 1975-1999 [in Japanese]. Nihon Eiseigaku Zasshi. 2002;57(3):571-584.
54. Zucs P, Buchholz U, Haas W, et al. Influenza associated excess mortality in Germany, 1985-2001. Emerg Themes Epidemiol. 2005;2:6.
55. Andreasen V, Simonsen L. The perils of using annual allcause mortality data to estimate pandemic influenza burden. Vaccine. 2011;29(suppl 2):B49-B55.
56. Bonmarin I, Belchior E, Levy-Bruhl D. Impact of influenza vaccination onmortality in the French elderly population during the 2000-2009 period. Vaccine. 2015;33(9):1099-1101.
57. Fleming DM. The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter. Commun Dis Public Health. 2000;3(1):32-38.
58. Fleming DM, Pannell RS, Cross KW. Mortality in children from influenza and respiratory syncytial virus. J Epidemiol Community Health. 2005;59(7):586-590.
59. Jansen AG, Sanders EA, Hoes AW, et al. Influenza-and respiratory syncytial virus-associated mortality and hospitalisations. Eur Respir J. 2007;30(6):1158-1166.
60. Murray CJ, Lopez AD, Chin B, et al. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: A quantitative analysis. Lancet. 2006;368(9554):2211-2218.
61. Richard SA, Sugaya N, Simonsen L, et al. A comparative study of the 1918-1920 influenza pandemic in Japan, USA and UK: mortality impact and implications for pandemic planning. Epidemiol Infect. 2009;137(8):1062-1072.
62. Thompson WW, Weintraub E, Dhankhar P, et al. Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respir Viruses. 2009;3(1):37-49.
63. Mamelund SE, Iversen BG. Morbidity and mortality in pandemic influenza in Norway [in Norwegian]. Tidsskr Nor Laegeforen. 2000;120(3):360-363.
64. Centers for Disease Control and Prevention. Estimates of deaths associated with seasonal influenza-United States, 1976-2007. MMWR Morb Mortal Wkly Rep. 2010;59(33): 1057-1062.
65. Centers for Disease Control and Prevention. What you should know and do this flu season if you are 65 years and older. http://www. cdc. gov/flu/about/disease/65over. htm. Accessed April 28, 2016.
66. Wong KK, Jain S, Blanton L, et al. Influenza-associated pediatric deaths in the United States, 2004-2012. Pediatrics. 2013;132(5):796-804.
67. Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005;353(24):2559-2567.
68. Hardelid P, Pebody R, Andrews N. Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999-2010. Influenza Other Respir Viruses. 2013;7(1):35-45.
69. Goldstein E, Viboud C, Charu V, et al. Improving the estimation of influenza-related mortality over a seasonal baseline. Epidemiology. 2012;23(6):829-838.
70. LipsitchM, Jha A, Simonsen L. Observational studies and the difficult quest for causality: lessons fromvaccine effectiveness and impact studies. Int J Epidemiol. 2016;45(6):2060-2074.
71. Brinkhof MW, Spoerri A, Birrer A, et al. Influenzaattributable mortality among the elderly in Switzerland. Swiss Med Wkly. 2006;136(19-20):302-309.
72. Carrat F, Valleron AJ. Influenza mortality among the elderly in France, 1980-90: how many deaths may have been avoided through vaccination J Epidemiol Community Health. 1995;49(4):419-425.
73. Dushoff J, Plotkin JB, Viboud C, et al. Mortality due to influenza in the United States-an annualized regression approach using multiple-cause mortality data. Am J Epidemiol. 2006;163(2):181-187.
74. Foppa IM, Cheng PY, Reynolds SB, et al. Deaths averted by influenza vaccination in the US during the seasons 2005/06 through 2013/14. Vaccine. 2015;33(26):3003-3009.
75. Foppa IM, Hossain MM. Revised estimates of influenzaassociated excess mortality, United States, 1995 through 2005. Emerg Themes Epidemiol. 2008;5:26.
76. Lemaitre M, Carrat F, Rey G, et al. Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS One. 2012;7(9):e45051.
77. Schanzer DL, Tam TW, Langley JM, et al. Influenzaattributable deaths, Canada 1990-1999. Epidemiol Infect. 2007;135(7):1109-1116.
78. Sprenger MJ, Mulder PG, Beyer WE, et al. Impact of influenza on mortality in relation to age and underlying disease, 1967-1989. Int J Epidemiol. 1993;22(2):334-340.
79. Alling DW, Blackwelder WC, Stuart-Harris CH. A study of excess mortality during influenza epidemics in the United States, 1968-1976. Am J Epidemiol. 1981;113(1):30-43.
80. Gran JM, Iversen B, Hungnes O, et al. Estimating influenzarelated excess mortality and reproduction numbers for seasonal influenza in Norway, 1975-2004. Epidemiol Infect. 2010;138(11):1559-1568.
81. Gran JM, Kacelnik O, Grjibovski AM, et al. Counting pandemic deaths: comparing reported numbers of deaths from influenza A(H1N1)pdm09 with estimated excess mortality. Influenza Other Respir Viruses. 2013;7(6):1370-1379.
82. Li CK, Choi BC, Wong TW. Influenza-related deaths and hospitalizations in Hong Kong: A subtropical area. Public Health. 2006;120(6):517-524.
83. Mann AG, Mangtani P, Russell CA, et al. The impact of targeting all elderly persons in England and Wales for yearly influenza vaccination: excess mortality due to pneumonia or influenza and time trend study. BMJ Open. 2013;3(8): e002743.
84. Nicholson KG. Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990. Epidemiol Infect. 1996;116(1):51-63.
85. Quandelacy TM, Viboud C, Charu V, et al. Age-and sexrelated risk factors for influenza-associated mortality in the United States between 1997-2007. Am J Epidemiol. 2014; 179(2):156-167.
86. Tillett HE, Smith JW, Clifford RE. Excess morbidity and mortality associated with influenza in England and Wales. Lancet. 1980;1(8172):793-795.
87. Tillett HE, Smith JW, Gooch CD. Excess deaths attributable to influenza in England and Wales: Age at death and certified cause. Int J Epidemiol. 1983;12(3):344-352.
88. Choi K, Thacker SB. Mortality during influenza epidemics in the United States, 1967-1978. Am J Public Health. 1982; 72(11):1280-1283.
89. Pitman RJ, Melegaro A, Gelb D, et al. Assessing the burden of influenza and other respiratory infections in England and Wales. J Infect. 2007;54(6):530-538.
90. Yu H, Feng L, Viboud CG, et al. Regional variation in mortality impact of the 2009 A(H1N1) influenza pandemic in China. Influenza Other Respir Viruses. 2013;7(6):1350-1360.
91. van Asten L, van den Wijngaard C, van Pelt W, et al. Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons. J Infect Dis. 2012;206(5):628-639.
92. Muscatello DJ, Newall AT, Dwyer DE, et al. Mortality attributable to seasonal and pandemic influenza, Australia, 2003 to 2009, using a novel time series smoothing approach. PLoS One. 2014;8(6):e64734.
93. Nielsen J, Mazick A, Glismann S, et al. Excess mortality related to seasonal influenza and extreme temperatures in Denmark, 1994-2010. BMC Infect Dis. 2011;11:350.
94. Ivan A, Freund S, Ionescu T, et al. Problem of excess mortality in influenza [in Romanian]. Viata Med. 1969; 16(21):1483-1491.
95. Mazick A, Gergonne B, Wuillaume F, et al. Higher all-cause mortality in children during autumn 2009 compared with the three previous years: pooled results from eight European countries. Euro Surveill. 2010;15(5):19480.
96. Azziz-Baumgartner E, Cabrera AM, Cheng PY, et al. Incidence of influenza-associated mortality and hospitalizations in Argentina during 2002-2009. Influenza Other Respir Viruses. 2013;7(5):710-717.
97. Viboud C, Grais RF, Lafont BA, et al. Multinational impact of the 1968 Hong Kong influenza pandemic: evidence for a smoldering pandemic. J Infect Dis. 2005;192(2):233-248.
98. Kuo HW, Schmid D, Liu YL, et al. Influenza-related excess mortality, Austria 2001 till 2009. Wien Klin Wochenschr. 2011;123(19-20):593-598.
99. Ansart S, Pelat C, Boelle PY, et al. Mortality burden of the 1918-1919 influenza pandemic in Europe. Influenza Other Respir Viruses. 2009;3(3):99-106.
100. Viboud C, Tam T, Fleming D, et al. 1951 influenza epidemic, England and Wales, Canada, and the United States. Emerg Infect Dis. 2006;12(4):661-668.
101. Rizzo C, Bella A, Viboud C, et al. Trends for influenzarelated deaths during pandemic and epidemic seasons, Italy, 1969-2001. Emerg Infect Dis. 2007;13(5):694-699.
102. Rizzo C, Viboud C, Montomoli E, et al. Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage. Vaccine. 2006;24(42-43): 6468-6475.
103. Charu V, Chowell G, Palacio Mejia LS, et al. Mortality burden of the A/H1N1 pandemic in Mexico: A comparison of deaths and years of life lost to seasonal influenza. Clin Infect Dis. 2011;53(10):985-993.
104. Nogueira PJ, Nunes B, Machado A, et al. Early estimates of the excess mortality associated with the 2008-9 influenza season in Portugal. Euro Surveill. 2009;14(18):19194.
105. Cohen C, Simonsen L, Kang JW, et al. Elevated influenzarelated excess mortality in South African elderly individuals, 1998-2005. Clin Infect Dis. 2010;51(12):1362-1369.
106. Simón Méndez L, López-Cuadrado T, López Perea N, et al. Premature mortality excess related to influenza in Spain during an interpandemic period [in Spanish]. Rev Esp Salud Publica. 2012;86(2):153-163.
107. Chowell G, Erkoreka A, Viboud C, et al. Spatial-temporal excess mortality patterns of the 1918-1919 influenza pandemic in Spain. BMC Infect Dis. 2014;14:371.
108. León-Gómez I, Delgado-Sanz C, Jiménez-Jorge S, et al. Excess mortality associated with influenza in Spain in winter 2012 [in Spanish]. Gac Sanit. 2015;29(4):258-265.
109. Nguyen AM, Noymer A. Influenza mortality in the United States, 2009 pandemic: burden, timing and age distribution. PLoS One. 2013;8(5):e64198.
110. Housworth J, Langmuir AD. Excess mortality from epidemic influenza, 1957-1966. Am J Epidemiol. 1974; 100(1):40-48.
111. Lui KJ, Kendal AP. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health. 1987;77(6):712-716.
112. Simonsen L, Reichert TA, Viboud C, et al. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med. 2005;165(3):265-272.
113. Serfling RE, Sherman IL, Houseworth WJ. Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics, United States, 1957-58, 1960 and 1963. Am J Epidemiol. 1967;86(2):433-441.
114. Simonsen L, Clarke MJ, Williamson GD, et al. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health. 1997;87(12):1944-1950.
115. Egger M, Jennings S, Spuhler T, et al. Mortality in influenza epidemics in Switzerland 1969-1985 [in German]. Schweiz Med Wochenschr. 1989;119(13-14):434-439.
116. Imaz MS, Eimann M, Poyard E, et al. Influenza associated excess mortality in Argentina: 1992-2002 [in Spanish]. Rev Chilena Infectol. 2006;23(4):297-306.
117. Kyncl J, Prochazka B, Goddard NL, et al. A study of excess mortality during influenza epidemics in the Czech Republic, 1982-2000. Eur J Epidemiol. 2005;20(4):365-371.
118. Nunes B, Viboud C, Machado A, et al. Excess mortality associated with influenza epidemics in Portugal, 1980 to 2004. PLoS One. 2011;6(6):e20661.
119. Stroup DF, Thacker SB, Herndon JL. Application of multiple time series analysis to the estimation of pneumonia and influenza mortality by age 1962-1983. Stat Med. 1988;7(10): 1045-1059.
120. Lee VJ, Chen MI, Chan SP, et al. Influenza pandemics in Singapore, a tropical, globally connected city. Emerg Infect Dis. 2007;13(7):1052-1057.
121. World Bank. World Bank country and lending groups. https:// datahelpdesk. worldbank. org/knowledgebase/articles/ 906519-world-bank-country-and-lending-groups. Accessed November 21, 2017.